- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06305091
DNA Methylation Markers in Veterans Exposed to Open Burn Pits
DNA Methylation Markers Associated With Exposure and Adverse Health Outcomes in Veterans Exposed to Airborne Hazards From Open Burn Pits
Background: The VA and DoD estimate that 3.5 million Veterans and Service Members were exposed to open burn pits used for waste disposal during military deployments to countries such as Kuwait, Afghanistan, and Iraq since 1990. Since the lasting adverse effects of this exposure on health are unknown, the VA Airborne Hazards and Open Burn Pit Registry (AHOBPR) was created. More than 209,000 participants to date have answered the registry questionnaire about the extent of exposure to burn pits and other airborne hazards. The questions attempted to quantify the duration of exposure, the severity of acute health effects, and the relative timing of onset or worsening of chronic respiratory, cardiovascular, neurological, and other illnesses. However, the AHOBPR interview lacks specific inquiry about mental health and biomarkers. The proposed study will recruit AHOBPR participants and non-participant for a follow-up enhanced evaluation of their health in a translational research study to better characterize their psychological, physical health profile, and potentially harmful epigenetic and biochemical exposure-related alterations.
Hypothesis: The investigators hypothesize that 1) the severity of individual exposure to burn pits will be positively correlated with levels of persistent organic pollutants in blood and metals in urine and specific epigenetic alterations in DNA methylation; and 2) levels of toxic chemicals and alterations in the methylation of specific genes will be positively correlated with chronic problems involving the cardiovascular, respiratory, neuropsychiatric and other systems.
Specific Aims: (1) Describe and quantify relationships of the intensity and duration of exposure with persistent organic chemicals/metals in the registry participants and ascertain their relationships with health outcomes linked to burn pit exposure. (2) Discover and validate DNA methylation marks that best distinguish between individuals exposed to burn pits and those not; then describe and quantify the relationships between DNA methylation, intensity and duration of exposure, and health outcomes. Completion of these aims will allow quantitation of the relationships between toxic chemicals, DNA methylation, and individual health problems.
Study Design: A clinical study will be conducted at the Central Arkansas Veterans Healthcare System and the University of Arkansas for Medical Sciences. The AHOBPR registry and non-specific recruitment will be used to enroll OBP exposed (N=220) and age and gender-matched unexposed (N=110) veterans. The unexposed veterans will be given the same questions as in the AHOBPR to determine their open burn pit exposure status with a confirmation of no exposure. A single study visit per participant will strengthen the registry by validating its contents using the electronic patient record and adding new study data on physical and mental function, including effects of epigenetic and toxicant measures obtained from blood and urine samples. Linear and logistic regression modeling will be used to determine the relationships described by the study aims while controlling for confounding variables and false discovery rates.
Long-term and Short-term Impact on Patient Populations: The immediate goal of the study is to measure exposure-related differences in levels of potentially toxic chemicals present in blood and urine and differences in DNA methylation. The study will then determine the relationships between exposure, the biochemical and molecular measures, and the presence of health problems. The value of this information is high since the effects of burn pit exposure are largely unknown but potentially serious. The longer-term goal for this line of investigation is to enable personalized and tailored health management for exposed individuals. The investigators believe that the biochemical and molecular measures may become novel biomarkers that enable the prediction of risk for disease and adverse disease outcomes such that preventative measures can be employed. Furthermore, the results will be highly relevant to other occupations in which exposure to airborne pollutants is high.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Kalpana Padala, MD, MS
- Phone Number: 501-257-2044
- Email: kalpana.padala@va.gov
Study Contact Backup
- Name: Trent Trice, BS
- Phone Number: 501-257-2403
- Email: trent.trice@va.gov
Study Locations
-
-
Arkansas
-
North Little Rock, Arkansas, United States, 72114
- Recruiting
- Central Arkansas Veterans Healthcare System (3J/NLR)
-
Contact:
- Trent Trice, BS
- Phone Number: 501-257-2403
- Email: trent.trice@va.gov
-
Contact:
- Kalpana Padala, MD
- Phone Number: 501-257-2044
- Email: kalpana.padala@va.gov
-
Principal Investigator:
- Kalpana Padala, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 25-70 years
- Participants that reside in Arkansas
- All Veterans that are deployed
- Participants registered in the AHOBPR burn pit registry mainly for exposed Veterans. However, unexposed participants from the registry could also be included.
- Participants not listed in the AHOBPR burn pit registry mainly for unexposed Veterans. However, exposed participants not from the registry could also be included.
- Non-smokers: defined as smoke less than 10 cigarettes during lifetime.
- Fluent in English
Exclusion Criteria:
- Any occupation and/or hobbies involves diesel exhaust, welding, paint, or other chemical fumes or organic dust
- Any use of tobacco or nicotine products within the past year, such as smoking (cigarettes, pipes, cigars, e-cigarettes, vaping devices)
- Self-report and/or chart review that patient is pregnant
- Self-report and/or chart review that patient weight is less than 110 lbs
- Participants whom the PI deems to be otherwise ineligible
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
OBP exposed
Veterans exposed to Open Burn Pits (N=220)
|
Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples
|
|
OBP not exposed
Veterans not exposed to Open Burn Pits (N=110)
|
Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
DNA methylation markers and heavy metals
Time Frame: Day 1
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Physical and mental health comorbidities
Time Frame: Day 1
|
Day 1
|
Collaborators and Investigators
Investigators
- Principal Investigator: Kalpana Padala, MD, MS, Central Arkansas Veterans Healthcare System, Little Rock, AR
- Principal Investigator: Shuk-Mei Ho, PhD, University of Arkansas for Medical Sciences, Little Rock, AR
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1681559
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Open Burn Pit Exposure
-
VA Office of Research and DevelopmentNot yet recruiting
-
Creative Medical Technology Holdings IncWCG IRBNot yet recruitingBiomarkers | Respiratory Symptoms | Immune Dysfunction | Burn Pit Exposure | Airborne Hazard Exposure | Veteran Health | Deployment-Related Toxic Exposure
-
University of Rhode IslandUniversity of Louisville; Congressionally Directed Medical Research Programs; Louisville VA Medical CenterNot yet recruitingHyperlipidemia (E.G., Hypercholesterolemia) | Environmental Exposures | Occupational Exposure to Chemicals | Burn Pit Exposure | Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia | PFAS | Military Exposure | Forever ChemicalsUnited States
-
Implandata Ophthalmic Products GmbHCompletedCongenital Glaucoma | Stevens-Johnson Syndrome | Graft vs Host Disease | Congenital Aniridia | Chemical BurnsGermany
Clinical Trials on Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples
-
King's College LondonDelosis Limited; NeuroSpinCompletedAnorexia Nervosa | Binge-Eating Disorder | Bulimia NervosaUnited Kingdom
-
Ana Catarina Navarro RamalhoActive, not recruitingDepression | Anxiety | Chronic Musculoskeletal PainBelgium
-
MeLSyTech, LtdCompletedUrinary Incontinence | Sexual Dysfunction | Vaginal Atrophy | Postoperative Care | Preoperative Care | Female Urogenital Diseases | Menopausal Syndrome | Prolapse Genital | Postpartum Period | Postmenopausal Period | Vaginal ProlapseRussian Federation
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingSmoking Cessation | Tobacco-Related CarcinomaUnited States
-
Assistance Publique Hopitaux De MarseilleAix Marseille Université; UMR 5203, InsermU1191, IGF, Montpellier; CRMBM-CEMEREMNot yet recruitingDrug Resistant Epilepsy
-
Freeman-Sheldon Research Group, Inc.WithdrawnCraniofacial Abnormalities | ArthrogryposisUnited States
-
Glenn-Milo SantosNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedSexually Transmitted Diseases | Alcohol Use DisorderUnited States
-
Freeman-Sheldon Research Group, Inc.TerminatedDepressive Disorder | Craniofacial Abnormalities | Posttraumatic Stress Disorder | ArthrogryposisUnited States, Guatemala
-
Uganda Cancer InstituteFogarty International Center of the National Institute of Health; Varian Medical...RecruitingCervical Cancer | Cervix Cancer | Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Small Cell CarcinomaUganda
-
Washington University School of MedicineEdward P. Evans FoundationRecruitingCardiovascular Diseases | Aged | Geriatrics | Geriatric SyndromesUnited States